David Lemus

Insider Reports History

Location
San Diego, CA
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Lemus:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Scilex Holding Co Director Common Stock 2K $1.8K $0.90 17 Oct 2024 Direct
Sorrento Therapeutics, Inc. Director Stock option (right to buy) 250K 30 Aug 2021 Direct
Scilex Holding Co Director Nonstatutory Stock Option (right to buy) 100K 15 Mar 2024 Direct
Silence Therapeutics plc Director Share Option (Right to Buy) 48K 02 Jan 2025 Direct
Silence Therapeutics plc Director Ordinary Shares 7.53K 02 Jan 2025 Direct

Insider Reports Filed by David Lemus

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SLN Silence Therapeutics plc 02 Jan 2025 1 $0 4 Director 06 Jan 2025, 16:15
SLN Silence Therapeutics plc 02 Jan 2025 0 $0 3 Director 02 Jan 2025, 16:29
SCLX Scilex Holding Co 17 Oct 2024 1 $1.8K 4 Director 18 Oct 2024, 09:10
SCLX Scilex Holding Co 15 Mar 2024 1 $0 4 Director 26 Jun 2024, 21:29
SCLX Scilex Holding Co 17 Jan 2023 1 $0 4 Director 17 Jan 2023, 16:28
SCLX Vickers Vantage Corp. I 10 Nov 2022 0 $0 3 Director 15 Nov 2022, 17:26
SRNEQ Sorrento Therapeutics, Inc. 30 Aug 2021 1 $0 4 Director 30 Aug 2021, 20:13